Cargando…
Comparison of effects of a single dose of MHYOSPHERE® PCV ID with three commercial porcine vaccine associations against Mycoplasma hyopneumoniae (Mhyo) and porcine circovirus type 2 (PCV2) on piglet growth during the nursery period under field conditions
Pigs routinely undergo stressful vaccination procedures, which are often unavoidable given the unavailability of safer alternatives, challenging animal welfare. The available vaccines for Mycoplasma hyopneumoniae (Mhyo) or Porcine circovirus type 2 (PCV2) are mostly administered intramuscularly in a...
Autores principales: | Puig, Ainhoa, Bernal, Ignacio, Sabaté, David, Ballarà, Isaac, Montané, Jordi, Nodar, Lorena, Angelats, Daniel, Jordà, Ramon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684222/ https://www.ncbi.nlm.nih.gov/pubmed/35829861 http://dx.doi.org/10.1007/s11259-022-09971-y |
Ejemplares similares
-
Effect of porcine circovirus type 2 (PCV2) vaccination on PCV2-viremic piglets after experimental PCV2 challenge
por: Seo, Hwi Won, et al.
Publicado: (2014) -
A Dual Swine Challenge With Porcine Circovirus Type 2 (PCV2) and Mycoplasma hyopneumoniae Used to Compare a Combination of Mixable Monovalent PCV2 and Monovalent M. hyopneumoniae Vaccines With a Ready-to Use PCV2 and M. hyopneumoniae Bivalent Vaccine
por: Yang, Siyeon, et al.
Publicado: (2020) -
A Comparison of Pathogenicity and Virulence of Three Porcine Circovirus Type 2 (PCV2) Genotypes (a, b, and d) in Pigs Singularly Inoculated with PCV2 and Dually Inoculated with Mycoplasma hyopneumoniae and PCV2
por: Oh, Taehwan, et al.
Publicado: (2021) -
Effect of Porcine circovirus 2 (PCV-2) maternally derived antibodies on performance and PCV-2 viremia in vaccinated piglets under field conditions
por: Figueras-Gourgues, S., et al.
Publicado: (2019) -
First detection of porcine circovirus 4 (PCV-4) in Europe
por: Holgado-Martín, Rocío, et al.
Publicado: (2023)